Clinical Trial Update: Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of modified-release prednisone (Lodotra) for active rheumatoid arthritis has completed, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Lodotra (prednisone)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-12-13